Text Size

ADL- Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)

This study has been completed.
Sponsor:
Information provided by:
LHL Helse
ClinicalTrials.gov Identifier:
NCT00887705
First received: April 14, 2009
Last updated: June 22, 2010
Last verified: June 2010
History of Changes
  Purpose

ADL training of copd patients results in better execution of activities of daily living.


Condition Intervention
Chronic Obstructive Pulmonary Disease
 Behavioral: ADL training

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Activities of Daily Living (ADL)-Training for Patients With Chronic Obstructive Pulmonary Disease (COPD)

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by LHL Helse:

Primary Outcome Measures:
  • Canadian Occupational Performance Measure(COPM) - Self-perception of occupational performance and satisfaction. [ Time Frame: Baseline, 4 weeks; 3 months ] [ Designated as safety issue: No ]

Enrollment: 24
Study Start Date: May 2009
Study Completion Date: June 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1: Standard rehabilitation programme
Experimental: 2. Additional ADL training Behavioral: ADL training
The control group gets the standard rehabilitation programme which includes one hour ADL- training. The experimental group also gets the standard rehabilitation program, but instead of one hour they get an additional five hours ADL- training.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD
  • Referred for rehabilitation
  • Age > 18 years
  • Symptoms affecting ADL function
  • 6 minute walk distance (6MWD) < 400 meters

Exclusion Criteria:

  • Patients who smokes or has smoked during the last three months.
  • LTOT
  • Patients who has another disability
  • Patients who can`t read or speak Norwegian
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00887705

Locations
Norway
Glittreklinikken
Hakadal, Akershus, Norway, 1485
Glittreklinikken
Hakadal, Norway, 1485
Sponsors and Collaborators
LHL Helse
Investigators
Study Director: Morten S Ryg, Dr philos LHL Helse
  More Information

Additional Information:
Site of LHL (Norwegian association for lung and heart disease patients). Glittreklinikken is listed as part of the organization  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Morten Ryg, Glittreklinikken
ClinicalTrials.gov Identifier: NCT00887705     History of Changes
Other Study ID Numbers: GK-63
Study First Received: April 14, 2009
Last Updated: June 22, 2010
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Norway: Norwegian Institute of Public Health

Keywords provided by LHL Helse:
COPD
Pulmonary Rehabilitation
ADL-Training
COPD Rehabilitation

Additional relevant MeSH terms:
Lung Diseases
Respiration Disorders
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 23, 2013